4//SEC Filing
Skvarka Jan 4
Accession 0001725160-22-000165
CIK 0001725160other
Filed
Sep 11, 8:00 PM ET
Accepted
Sep 12, 7:07 AM ET
Size
5.0 KB
Accession
0001725160-22-000165
Insider Transaction Report
Form 4
Skvarka Jan
Director
Transactions
- Award
Common Stock
2022-09-09+36,606→ 36,606 total
Footnotes (1)
- [F1]The restricted stock units ("RSUs") were granted by the Issuer pursuant to the Issuer's Non-Employee Director Compensation Program. One third of the RSUs will vest on each of the first, second and third anniversaries of the grant date, subject to the reporting person's continued service with the Issuer on each vesting date.
Documents
Issuer
Zentalis Pharmaceuticals, Inc.
CIK 0001725160
Entity typeother
Related Parties
1- filerCIK 0001838042
Filing Metadata
- Form type
- 4
- Filed
- Sep 11, 8:00 PM ET
- Accepted
- Sep 12, 7:07 AM ET
- Size
- 5.0 KB